About

Recent Posts

  • Medtronic To Buy Osteotech In $123 Million Friendly Takeover
  • Wound Care: Finding a Niche
  • Creating a Winning Medtech Business Model for a Post-Reform World
  • EndoControl SAS
  • Medtronic Expands Ortho Biologics Presence With Osteotech Acquisition
  • Medical Device User Fee Negotiations: Here We Go Again
  • Seeking New Options for Prostate Cancer
  • Industry Preps For Excise Tax Implementation While Repeal Effort Continues
  • 'Least Burdensome' Provisions Revisited In FDA Regulatory Science Report
  • Raising Robotics: An Interview with Intuitive's Lonnie Smith

Add to Google Reader or Homepage

Subscribe in NewsGator Online

Subscribe in Bloglines

Notices

Related Posts with Thumbnails

« Industry In Focus: US Home Health Care Revenues Set to Exceed $5 Billion by 2012 | Main | Combination Product Rules Clear OMB, To Be Released In Weeks »

September 21, 2009

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00d83452f00669e20120a58958d7970b

Listed below are links to weblogs that reference Device Firms Dig In Against Baucus Fee, Despite Class I, Revenue Exceptions :

Comments

The comments to this entry are closed.